RxDoctor Payments Data

Guy Young

Pediatric Hematology-Oncology · Bozeman, MTNPI 1629175195

Payments from drug & device makers

$5,086,753in general payments, 2019–2025

Across 2,963 payments — averaging $1716.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1.1M
  • Novo Nordisk AS$571K
  • Genentech, Inc.$563K
  • Takeda Pharmaceuticals U.S.A., Inc.$462K
  • CSL Behring$339K
  • Grifols Shared Services North America, Inc.$290K
  • plus $1.8M from 32 others
$47,327in research payments, 2019–2025

Across 45 payments — averaging $1051.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$36K
  • Sanofi$9K
  • Bioverativ Therapeutics Inc.$2K

What the payments were for

  • Consulting fees$758,67230%
  • Speaking & faculty fees$1,338,46653%
  • Travel & lodging$390,07515%
  • Food & beverage$28,6071%
  • Education$1,0320%
  • Gifts$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Montanato place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Bozeman

Where these figures come from

Is this you, or does something look wrong? →